Page 217 - Health Medical Pharma

Strides Pharma up 6% as JV gets USFDA nod for tapeworm infection drug

Shares of Strides Pharma Science Tuesday gained over 6 per cent after its joint venture with Vivimed Labs received approval from the US health regulator for Albendazole tablets, used in the treatment of certain infections caused by tapeworm. The stock settled at Rs 458.4 on BSE, a jump of 6.42 per cent. During the day, it rose 7.28 per cent to Rs 462.15. On NSE, scrip advanced 6.57 per cent to close at Rs 459.2. It soared 7.53 per cent to touch an intra-day of Rs 463.35. In terms of equity volume, 1.8 lakh shares of the company were traded on BSE and over 23 lakh scrips changed hands on NSE during the day. In a regulatory filing, Strides Pharma said that Strides Vivimed, Singapore, has received approval from the United States Food and Drug Administration (USFDA) for Albendazole tablets, in the strength of 200 mg. It is a generic version of Amneal Pharmaceuticals Inc's Albenza tablets. Strides Vivimed is a 50:50 joint venture between Strides Pharma and Vivimed Labs.

PM may visit Tripura in Feb to inaugurate projects: Official

Prime Minister Narendra Modi is scheduled to visit Tripura in February to inaugurate several development projects, including an upgraded cancer centre, a government official said. The regional centre, which offers treatment to more than 2,000 cancer patients annually, is set to have a new building and modern equipment, he said. According to government reports, 3,786 patients succumbed to cancer between 2013 and 2016 in the state. Sanjoy Mishra, the media adviser to chief minister Biplab Kumar Deb, said a high-level meeting was convened Monday to review progress in the cancer hospital project. "The Prime Minister is scheduled to visit Tripura in February to inaugurate several developmental projects. The newly built building at the cancer centre is one of them. Chief Minister Biplab Kumar Deb on Monday reviewed the progress of the construction work at the centre," Mishra said. Chief Secretary LK Gupta, Public Works Department (PWD) secretary Manoj Kumar and Health and ...

James Bond has severe drinking disorder: Study

British secret service agent James Bond may be licensed to kill, but scientists say that his severe alcohol use disorder may prove to be fatal for the popular fictional character. Researchers from University of Otago in Australia analysed 24 Bond movies produced between 1962 and 2015, and found the secret agent has been drinking heavily and consistently over six decades. Despite his preference for martinis (shaken, not stirred), the researchers found Bond was ready to drink any alcoholic beverage that was available, from neat vodka to champagne -- even occasionally beer. Bond frequently engaged in hazardous activities while under the influence, according to the study published in the Medical Journal of Australia. "Chronic risks include frequently drinking prior to fights, driving vehicles (including in chases), high stakes gambling, operating complex machinery or devices, contact with dangerous animals, extreme athletic performance and sex with enemies, sometimes with guns or knives ..

Late childbirth linked to high breast cancer risk: Study

Women who had their first child after 35 may be at an increased risk of developing breast cancer than their peers who do not have children, according to a study contrary to conventional wisdom that childbirth is protective against breast cancer.

Strides Pharma spurts as JV receives approval

Strides Pharma Science advanced 6.27% to Rs 457.75 at 15:16 IST on BSE after the company announced that its joint venture has received approval for Albendazole Tablets.

Regular flu shots might save heart failure patients

Annual flu vaccination is regarded as a safe and low-cost way to improve survival rate among elderly heart failure patients, according to a new research.

Coffee compounds may help fight Parkinson's: Study

Scientists have identified a compound in coffee that could be teamed up with caffeine to fight Parkinson's disease and Lewy body dementia -- two currently incurable neurodegenerative disorders. The discovery, published in the journal Proceedings of the National Academy of Sciences, suggests these two compounds combined may become a therapeutic option to slow brain degeneration. Prior research has shown that drinking coffee may reduce the risk of developing Parkinson's disease. While caffeine has traditionally been credited as coffee's special protective agent, coffee beans contain more than a thousand other compounds that are less well known. Researchers from Rutgers University in the US focused on a fatty acid derivative of the neurotransmitter serotonin, called EHT (Eicosanoyl-5-hydroxytryptamide), found in the bean's waxy coating. They found that EHT protects the brains of mice against abnormal protein accumulation associated with Parkinson's disease and Lewy body dementia. In the .

Strides Pharma JV gets USFDA nod for tapeworm infection treatment drug

Drug firm Strides Pharma Science Tuesday said its joint venture (JV) firm has received approval from the US health regulator for Albendazole tablets, used in the treatment of certain infections caused by tapeworm. Strides Vivimed Pte Ltd, Singapore, a 50:50 joint venture with Vivimed Labs, has received approval from the United States Food & Drug Administration (US FDA) for Albendazole tablets in the strength of 200 mg, Strides Pharma Science said in a BSE filing. This is the second generic approval by US FDA for Albendazole tablets, the company added. Strides Pharma Science said the approved product is a generic version of Amneal Pharmaceuticals Inc's Albenza tablets. Quoting IQVIA MAT data, Strides Pharma Science said the US market for Albendazole tablets USP 200 mg is approximately USD 100 million. Shares of Strides Pharma Science were trading 1.22 per cent higher at Rs 436 apiece on BSE.

Lupin gains after getting approval for Apixaban Tablets

Lupin rose 2.13% to Rs 832.45 at 13:25 IST on BSE after the company received tentative US FDA approval for Apixaban Tablets, 2.5 mg and 5 mg.

'Cervical cancer is largely preventable'

Nearly 74,000 women-a fifth of the global cases-die every year in India from -cervical cancer, a largely preventable malady. With Intensified screening developed countries have considerably reduced the deaths from cervical cancer, a leading expert has offered India help to benefit from the global experience in terms of prioritizing screening and prevention.

New spray gel could help fight cancer after surgery

Scientists have developed a spray gel embedded with immune-boosting drugs which they say could help the body fight off cancer after surgery. Many people who are diagnosed with cancer will undergo some type of surgery to treat their disease, said researchers from the University of California, Los Angeles (UCLA) in the US. Almost 95 per cent of people with early-diagnosed breast cancer will require surgery and it is often the first line of treatment for people with brain tumours, according to the study published in the journal Nature Nanotechnology. However, despite improvements in surgical techniques over the past decade, the cancer often comes back after the procedure. The researchers tested the biodegradable spray gel in mice that had advanced melanoma tumours surgically removed. They found that the gel reduced the growth of the tumour cells that remained after surgery, which helped prevent recurrences of the cancer. After receiving the treatment, 50 per cent of the mice survived for

Liva Pharmaceuticals gets USFDA approval for its sANDA - Ranitidine Injection

Ranitidine belongs to the class of medications called H2antagonists and is used to treat stomach and duodenal (intestinal) ulcers, and prevent them from recurring. It is also used to treat gastroesophageal reflux disease (GERD) and ZollingerEllison Syndrome. The injectable form ofranitidine is given for short-term treatment of these conditions when a patient is unable to take this medication orally.

Dates, apricots better than starchy foods in lowering diabetes

Eating dried fruits such as dates, apricots, raisins and sultanas may not spike blood sugar compared to starchy foods such as white bread, suggests a study.

New Zealand parliament passes medicinal marijuana bill

New Zealand's parliament on Tuesday passed a bill that will allow the medicinal use of marijuana, making it possible for patients with chronic pain to acquire the drug with a prescription.

New Zealand law to make medical marijuana widely available

New Zealand's government on Tuesday passed a law that will make medical marijuana widely available for thousands of patients over time. The legislation will also allow terminally ill patients to begin smoking illegal pot immediately without facing the possibility of prosecution. The measures come ahead of a planned national referendum on recreational marijuana use. The government has pledged to hold the referendum some time over the next two years, but has not yet set a date or finalized the wording. The new law allows patients much broader access to medical marijuana, which was previously highly restricted. But most patients will have to wait a year until a new set of regulations, licensing rules and quality standards are put in place. The law will also allow medical marijuana products to be manufactured in New Zealand for both domestic and overseas markets. Health Minister Dr. David Clark said in a statement the new law will help ease suffering. "This will be particularly welcome ..

Brain tumors may respond to immunotherapy: Study

According to a recent study, a slow-growing brain tumor in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which helps to boost the immune system in fighting cancer.The study, led by researchers at Columbia University showed that a lot of have NF1, a hereditary disease that can lead to the development of tumors throughout the nervous system, including a type of brain tumor called a glioma.The findings of the study are published in the Journal of Nature Medicine.Gliomas are most highly resistant to chemotherapy, and radiotherapy aggravates, rather than relieve, symptoms, such as headaches and seizures. Since the tumors typically engulf delicate brain regions, surgery is rarely an option.Immunotherapy has been successful for some patients with melanoma, lymphoma, and a few other types of cancer. But some clinical trials have shown that it is ineffective for brain cancers in general.In this study, researchers performed an in-depth analysis of tumor

Strides Vivimed JV receives USFDA approval for Albendazole Tablets

Albendazole Tablets is a generic version of Albenza Tablets of Amneal Pharmaceuticals, Inc. According to IQVIA MAT data, the US market for Albendazole Tablets USP 200 mg is approximately US$ 100 Mn.

Dr Reddys Laboratories launches Omeprazole Delayed-Release Tablets in US market

OTC Omeprazole Delayed-Release Tablets, 20 mg, is a proton pump inhibitor used to treat frequent heartburn occurring two or more days per week in adults.

Siddaganga seer Shivakumara Swami stable, recovering

Shivakumara Swami of Siddaganga Mutt was recovering well from the operation he underwent at Dr Rela Institute and Medical Centre here and is communicating well. He underwent an operation at the hospital on December 8 to treat his liver and bile duct infection."Shri Shri Shivakumara Swamigalu is recovering well from the operation. He is conscious, well oriented and is communicating well," read a Press Release from Dr Rela Institute and Medical Centre.The statement further stated that the seer is gently beginning to mobilise in the Intensive Care Unit and his vitals are stable.Shivakumara Swami is a Lingayat religious figure and humanitarian and head of Sree Siddaganga Matha described as the most esteemed adherent of Lingayatism.

Jaya did not have heart diseases, cardiologist tells panel

: A cardio thoracic surgeon of Apollo Hospital Monday deposed before a panel probing the death of former Chief Minister late J Jayalalithaa, that she did not have any heart diseases. The Justice A Arumughaswamy Commission of Inquiry examined Dr L F Sridhar,a cardio thoracic surgeon and was among doctors who attended to Jayalalithaa during her hospitalisation. The panel has examined several doctors on Jayalalithaa's health issues and complications, the diagnostic tests done and treatment options pursued as part of its fact finding exercise. N Raja Senthhoor Pandian, counsel for V K Sasikala, confidante of the late Jayalalithaa, told reporters that he asked the surgeon if vegetation in the mitral valve of the late leader was the reason for the cardiac arrest she suffered on December 4, 2016. "The doctor replied that it was not the reason and he also testified that the late leader did not have any heart diseases and there was no need for any (cardiac) surgery," he said. To